Results 61 to 70 of about 8,062,145 (231)

Atomic‐Scale Structurally Locked 1T/2H‐MoS2/ZnS Z‐Scheme Heterojunctions for Prolonged Charge Kinetics and Dual‐Functional Photocatalysis

open access: yesENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Atomic‐scale structurally locked 1T/2H‐MoS2/ZnS direct Z‐scheme heterojunction enabling dual‐functional photocatalysis. The metallic 1T‐MoS2 phase serves as an electronic actuator that bridges charge transfer across the heterointerface, resulting in prolonged charge kinetics, efficient hydrogen evolution, and complete degradation of Malachite Green ...
Jeongjin Lee   +10 more
wiley   +1 more source

Kramerman, Harry (Box 90, Folder 24)

open access: yes, 1976
Series VIII: Audiocassettes features informal oral histories about the Hebrew Orphan Asylum and its alumni.Digital recordingDigital finding ...
Hebrew Orphan Asylum of New York
core  

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer   +25 more
wiley   +1 more source

Bernstein, Edna, Kaminsky, Ceil, and Lit, Sara Liman (Box 90, Folder 8)

open access: yes, 1977
Series VIII: Audiocassettes features informal oral histories about the Hebrew Orphan Asylum and its alumni.Digital recordingDigital finding ...
Hebrew Orphan Asylum of New York
core  

Transcriptomic analysis reveals distinct expression patterns in focal cortical dysplasia

open access: yesEpilepsia, EarlyView.
Abstract Objective Focal cortical dysplasia (FCD) is a common cause of drug‐resistant epilepsy in children and adults and exhibits substantial clinical and histopathological heterogeneity. However, morphological classification alone does not fully explain variability in epileptogenicity, disease severity, or treatment response.
Shivani Sonawane   +20 more
wiley   +1 more source

Badian, Sam (Box 90, Folder 5)

open access: yes, 1976
Series VIII: Audiocassettes features informal oral histories about the Hebrew Orphan Asylum and its alumni.Digital recordingDigital finding ...
Hebrew Orphan Asylum of New York
core  

Sources of Orphan Drug-related clinical trial data.

open access: yes, 2022
Sources of Orphan Drug-related clinical trial data.
Mohua Chakraborty Choudhury (12446723)   +2 more
core   +1 more source

Perspectives on stimulating industrial research and development for neglected infectious diseases

open access: yesBulletin of the World Health Organization, 2001
This paper summarizes recent thinking on stimulating industrial research and development (R & D) for neglected infectious diseases and argues that it is critical to enlarge the value of the market for medicines and vaccines through, for example, global ...
Webber David, Kremer Michael
doaj  

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

Berman, Hilda (Box 90, Folder 7)

open access: yes, 1986
Series VIII: Audiocassettes features informal oral histories about the Hebrew Orphan Asylum and its alumni.Digital recordingDigital finding ...
Hebrew Orphan Asylum of New York
core  

Home - About - Disclaimer - Privacy